By activating GLP-1 receptors, retatrutide promotes insulin secretion in a glucose-dependent manner, reduces glucagon release, and slows gastric emptying all of which contribute to improved blood glucose control and reduced appetite
This reference does not imply that he supports, promotes, or recommends the purchase, sale, or use of this compound in any way
Higher concentrations allow smaller injection volumes but require more precise measurement
Current availability and out-of-pocket cost are confirmed through official manufacturer resources and local pharmacy networks
doi: 10.1530/EJE-07-0358 41 PetrossiansPDalyAFNatchecEMaioneLBlijdorpKSahnoun-FathallahMet al
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Collaboration PS